These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Molecular and cellular biological analysis on cancer cachexia syndrome]. Mukaiyama T Gan To Kagaku Ryoho; 2001 Jul; 28(7):883-91. PubMed ID: 11478136 [TBL] [Abstract][Full Text] [Related]
65. Metabolic balance across the leg in weight-losing cancer patients compared to depleted patients without cancer. Bennegård K; Edén E; Ekman L; Scherstén T; Lundholm K Cancer Res; 1982 Oct; 42(10):4293-9. PubMed ID: 7105024 [No Abstract] [Full Text] [Related]
66. Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome. Henriques FS; Sertié RAL; Franco FO; Knobl P; Neves RX; Andreotti S; Lima FB; Guilherme A; Seelaender M; Batista ML FASEB J; 2017 May; 31(5):1976-1986. PubMed ID: 28138038 [TBL] [Abstract][Full Text] [Related]
67. Energy balance and body composition in cancer patients. Warnold I; Lundholm K; Scherstén T Cancer Res; 1978 Jun; 38(6):1801-7. PubMed ID: 647689 [No Abstract] [Full Text] [Related]
68. [PTHrP and cancer cachexia]. Onuma E; Okabe H Clin Calcium; 2008 Apr; 18(4):489-98. PubMed ID: 18379031 [TBL] [Abstract][Full Text] [Related]
70. MCG101-induced cancer anorexia-cachexia features altered expression of hypothalamic Nucb2 and Cartpt and increased plasma levels of cocaine- and amphetamine-regulated transcript peptides. Burgos JR; Iresjö BM; Smedh U Oncol Rep; 2016 Apr; 35(4):2425-30. PubMed ID: 26780979 [TBL] [Abstract][Full Text] [Related]
71. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect. Akamizu T; Kangawa K Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929 [TBL] [Abstract][Full Text] [Related]
72. [The cachexia-anorexia syndrome among oncological patients]. Sosa-Sánchez R; Sánchez-Lara K; Motola-Kuba D; Green-Renner D Gac Med Mex; 2008; 144(5):435-40. PubMed ID: 19043964 [TBL] [Abstract][Full Text] [Related]
73. Cancer cachexia in man: a review. Strain AJ Invest Cell Pathol; 1979; 2(3):181-93. PubMed ID: 391780 [TBL] [Abstract][Full Text] [Related]
74. The Kleine-Levin syndrome. Some further observations. Garland H; Sumner D; Fourman P Neurology; 1965 Dec; 15(12):1161-7. PubMed ID: 5295527 [No Abstract] [Full Text] [Related]
75. The significance of learned food aversions in the aetiology of anorexia associated with cancer. Levine JA; Emery PW Br J Cancer; 1987 Jul; 56(1):73-8. PubMed ID: 3476146 [TBL] [Abstract][Full Text] [Related]
76. Parabiotic transfer of cancer anorexia/cachexia in male rats. Norton JA; Moley JF; Green MV; Carson RE; Morrison SD Cancer Res; 1985 Nov; 45(11 Pt 1):5547-52. PubMed ID: 3863707 [TBL] [Abstract][Full Text] [Related]
78. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia. Currow DC; Skipworth RJ Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564 [TBL] [Abstract][Full Text] [Related]
79. The Evolving Approach to Management of Cancer Cachexia. Dev R; Wong A; Hui D; Bruera E Oncology (Williston Park); 2017 Jan; 31(1):23-32. PubMed ID: 28090619 [TBL] [Abstract][Full Text] [Related]
80. [Hyperphagia and hepatic steatosis in the goose after lesion of the ventromedial nuclleus of the hypothalamus]. Auffray P; Blum JC C R Acad Hebd Seances Acad Sci D; 1970 May; 270(19):2362-5. PubMed ID: 4997615 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]